Site intended for healthcare professionals. Visit patient site.

FusionVu

A Practical Fusion Approach

FusionVu is an advanced elastic fusion feature designed to seamlessly integrate MRI imaging with the ExactVu micro-ultrasound platform, delivering a faster, more precise, and more intuitive targeting compared to standard fusion workflows. 

Built for Speed and Simplicity

FusionVu enables quick import, alignment, and targeting of MRI-identified lesions. Its streamlined workflow reduces procedural complexity, allowing clinicians to focus on what matters most - accurate diagnosis and patient care.

With 70-micron resolution, ExactVu micro-ultrasound allows many MRI-identified lesions to be visualized directly in real time. This enables:

  • Highly precise, real-time targeting 

  • Reduced dependence on software-based alignment 

  • Greater confidence in lesion localization 

Real-Time Tissue Characterization

FusionVu is enhanced by the PRI-MUS™ risk identification protocol, which helps clinicians differentiate and characterize prostate tissue in real time. This added layer of insight supports more informed clinical decision-making during the biopsy procedure.

Reducing the Limitations of Conventional Fusion

Standard elastic fusion workflows depend on aligning MRI with conventional ultrasound, where limited image clarity and patient positioning can impact accuracy. With sensors embedded directly in the probe for accurate tracking, FusionVu’s 3D elastic registration ensures precise alignment, enabling fast and reliable targeted biopsy guidance.

The Result: Confidence at Every Step

FusionVu delivers fast, simple, precise anatomical alignment, with suspicious targets documented directly within the workflow, empowering clinicians with real-time visualization, improved accuracy, and streamlined reporting.  

FusionVu Cases

 

MRI Identified a PI-RADS 2 lesion in the right anterior apex horn.

The right anterior apex horn lesion was targeted on micro-ultrasound utilizing FusionVu (PRI-MUS 5).

Gleason 3+4/GG 2; 3 of 3 cores with cribriform glands

 

MRI identified a PI-RADS 4 lesion in the left Transition Zone. The MRI PI-RADS 4 lesion was a negative sample.

Apical / Anterior zone lesion was identified on Micro-Ultrasound, next to the MRI lesion.

Gleason 3+4 cancer was identified within the Micro-Ultrasound sample.

Weasis-screen-small

 

DICOM Viewer 

Free DICOM Viewer compatible with FusionVu is available on our Downloads page.

 

DOWNLOADS